Press & News

2019-07-16

Solna, Sweden, July 16, 2019. Affibody AB (“Affibody”), a clinical stage biopharmaceutical company developing...[read more]

Financial Calendar

2019

May
Interim Report Q1 – May 17, 2019

Affibodys latest Press releases

2019-07-16

Affibody Announces Interim Analysis in Phase 2 Psoriasis Trial of ABY-035

Solna, Sweden, July 16, 2019. Affibody AB (“Affibody”), a clinical stage biopharmaceutical company developing a pipeline of innovative drug...[read more]

Press & News

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

About Affibody

Upcoming reports Financial calendar

Interim Report Q1 (May 17, 2019)

Investor information